{"mainPropery":{"diseaseId":10898,"diseaseName":"Acquired pure red cell aplasia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10898/acquired-pure-red-cell-aplasia","synonyms":["Idiopathic pure red cell aplasia","Adult pure red cell aplasia","Acquired PRCA"],"synonyms-with-source":[{"name":"Idiopathic pure red cell aplasia"},{"name":"Adult pure red cell aplasia"},{"name":"Acquired PRCA"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"98872"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"}],"organizations":[{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=acquired%20pure%20red%20cell%20aplasia' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Acquired pure red cell aplasia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?term=acquired+pure+red+cell+aplasia' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Acquired pure red cell aplasia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/506/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/205695-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98872' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:98872' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":5780,"questionText":"What is acquired&nbsp;pure red cell aplasia?","answerText":"<strong>Acquired pure red cell aplasia (PRCA)</strong> is a <a href=\"http://www.nlm.nih.gov/medlineplus/bonemarrowdiseases.html\" target=_blank>bone marrow disorder</a> characterized by&nbsp;a reduction of&nbsp;red blood cells (erythrocytes) produced by the bone marrow. Signs and symptoms may include fatigue, lethargy, and/or abnormal paleness of the skin (pallor) due to the <a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=_blank>anemia</a> the caused by the disorder.[4766] In most cases, the cause of acquired PRCA&nbsp;is unknown (idiopathic). In other cases it may occur secondary to <a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=_blank>autoimmune disorders</a>, tumors of the thymus gland (<a href=\"http://www.nlm.nih.gov/medlineplus/thymuscancer.html\" target=_blank>thymomas</a>), hematologic cancers, solid tumors, viral infections, or certain drugs.[4766][4767] Treatment&nbsp;depends on the cause of the condition (if known)&nbsp;but&nbsp;often includes transfusions for&nbsp;individuals who are severely anemic and have cardiorespiratory failure.[4767]","dateModified":"2011-12-14T14:33:00"},"basicQuestions":[{"questionId":5781,"questionText":"How might acquired pure red cell aplasia be treated?","answerText":"The main goals of treatment for pure red cell aplasia (PRCA) are to restore the production of red blood cells, maintain adequate hemoglobin levels, and treat underlying disorders that may be causing the condition. The initial treatment plan typically includes <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/bt/\" target=_blank>blood transfusions</a> for individuals who are severely <a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=_blank>anemic</a> and have cardiorespiratory failure.[4767] PRCA due to medication or infections is usually reversible within a few months. Therefore, medications that may be causing the condition should be discontinued, and infections that may cause the condition should be treated.[4767] Underlying conditions that may cause PRCA such as a <a href=\"http://www.nlm.nih.gov/medlineplus/thymuscancer.html\" target=_blank>thymoma</a>, hematological cancers, solid tumors, and <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001471/\" target=_blank>systemic lupus erythematosus</a> (SLE) should be treated as necessary as well.[4767]&nbsp;When the condition is idiopathic (of unknown cause)&nbsp;or due to an <a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=_blank>autoimmune disorder</a>, PRCA is typically initially treated with <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=_blank>corticosteroids</a>.[4767]<br><br>It has been reported that individuals who seem to be resistant to treatment may respond to a single course of <a href=\"http://www.itpkids.org/docs/ivig.html\" target=_blank>intravenous immunoglobulin</a> (IVIG,) while others have responded to a single dose. In the United States, financial issues may make it difficult to obtain this treatment because IVIG is expensive and is not approved by the&nbsp;Food and Drug Administration&nbsp;to treat PRCA.[4772]<br><br>Additional and more detailed information about the management of acquired PRCA may be found on eMedicine's web site and can be viewed by clicking <a href=\"http://emedicine.medscape.com/article/205695-treatment\" target=_blank>here</a>.","dateModified":"2011-12-15T14:47:00","resourceClassificationName":"Treatment","references":[{"referenceId":4766,"authors":"","articleTitle":"Pure Red Cell Aplasia, Acquired","bookWebsiteJournalTitle":"NORD","date":"August 7, 2007","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/506/viewAbstract","dateAccessed":"2011-12-14T00:00:00"},{"referenceId":4767,"authors":"Paul Schick","articleTitle":"Pure Red Cell Aplasia","bookWebsiteJournalTitle":"eMedicine","date":"October 25, 2011","url":"http://emedicine.medscape.com/article/205695-overview","dateAccessed":"2011-12-14T00:00:00"},{"referenceId":4772,"authors":"Stanley L Schrier","articleTitle":"Acquired pure red cell aplasia","bookWebsiteJournalTitle":"UpToDate","date":"2011","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":33316,"abbreviatedInquiry":"My uncle has had pure red cell aplasia for almost three years. About two years ago the hospital in my home town would not treat him&nbsp;anymore because they thought it was impossible to cure him. My mother transferred him to a bigger hospital in another city. Now he is taking medications for a very long time but his hemoglobin never goes up. The hospital said there is nothing to do if those medications don't work. My whole family is hopeless again now. Could you please help my uncle? He is only forty years old.","caseQuestions":[{"questionId":5781,"questionText":"How might acquired pure red cell aplasia be treated?","answerText":"The main goals of treatment for pure red cell aplasia (PRCA) are to restore the production of red blood cells, maintain adequate hemoglobin levels, and treat underlying disorders that may be causing the condition. The initial treatment plan typically includes <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/bt/\" target=_blank>blood transfusions</a> for individuals who are severely <a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=_blank>anemic</a> and have cardiorespiratory failure.[4767] PRCA due to medication or infections is usually reversible within a few months. Therefore, medications that may be causing the condition should be discontinued, and infections that may cause the condition should be treated.[4767] Underlying conditions that may cause PRCA such as a <a href=\"http://www.nlm.nih.gov/medlineplus/thymuscancer.html\" target=_blank>thymoma</a>, hematological cancers, solid tumors, and <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001471/\" target=_blank>systemic lupus erythematosus</a> (SLE) should be treated as necessary as well.[4767]&nbsp;When the condition is idiopathic (of unknown cause)&nbsp;or due to an <a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=_blank>autoimmune disorder</a>, PRCA is typically initially treated with <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=_blank>corticosteroids</a>.[4767]<br><br>It has been reported that individuals who seem to be resistant to treatment may respond to a single course of <a href=\"http://www.itpkids.org/docs/ivig.html\" target=_blank>intravenous immunoglobulin</a> (IVIG,) while others have responded to a single dose. In the United States, financial issues may make it difficult to obtain this treatment because IVIG is expensive and is not approved by the&nbsp;Food and Drug Administration&nbsp;to treat PRCA.[4772]<br><br>Additional and more detailed information about the management of acquired PRCA may be found on eMedicine's web site and can be viewed by clicking <a href=\"http://emedicine.medscape.com/article/205695-treatment\" target=_blank>here</a>.","dateModified":"2011-12-15T14:47:00","resourceClassificationName":"Treatment","references":[{"referenceId":4766,"authors":"","articleTitle":"Pure Red Cell Aplasia, Acquired","bookWebsiteJournalTitle":"NORD","date":"August 7, 2007","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/506/viewAbstract","dateAccessed":"2011-12-14T00:00:00"},{"referenceId":4767,"authors":"Paul Schick","articleTitle":"Pure Red Cell Aplasia","bookWebsiteJournalTitle":"eMedicine","date":"October 25, 2011","url":"http://emedicine.medscape.com/article/205695-overview","dateAccessed":"2011-12-14T00:00:00"},{"referenceId":4772,"authors":"Stanley L Schrier","articleTitle":"Acquired pure red cell aplasia","bookWebsiteJournalTitle":"UpToDate","date":"2011","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Acquired_pure_red_cell_aplasia"}